DCDC2 Gene Nephronophthisis Type 19 Genetic Test
Test Name: DCDC2 Gene Nephronophthisis Type 19 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for DCDC2 Gene Nephronophthisis Type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DCDC2 Gene Nephronophthisis Type 19 NGS Genetic DNA Test gene DCDC2
Test Details
The DCDC2 gene is associated with a rare genetic disorder called Nephronophthisis type 19 (NPHP19). Nephronophthisis is a progressive kidney disease that affects the function of the kidneys and can lead to end-stage renal disease.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of NPHP19, NGS genetic testing can be used to identify mutations or variations in the DCDC2 gene that may be responsible for the development of the disorder.
NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help identify individuals who are at risk of developing NPHP19, provide genetic counseling for affected individuals and their families, and guide the development of targeted therapies.
It is important to note that NGS genetic testing for NPHP19 or any other genetic disorder should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing should be carefully considered in the context of an individual’s clinical symptoms, family history, and other relevant factors.
Test Name | DCDC2 Gene Nephronophthisis type 19 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DCDC2 Gene Nephronophthisis type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DCDC2 Gene Nephronophthisis type 19 NGS Genetic DNA Test gene DCDC2 |
Test Details |
The DCDC2 gene is associated with a rare genetic disorder called Nephronophthisis type 19 (NPHP19). Nephronophthisis is a progressive kidney disease that affects the function of the kidneys and can lead to end-stage renal disease. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of NPHP19, NGS genetic testing can be used to identify mutations or variations in the DCDC2 gene that may be responsible for the development of the disorder. NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help identify individuals who are at risk of developing NPHP19, provide genetic counseling for affected individuals and their families, and guide the development of targeted therapies. It is important to note that NGS genetic testing for NPHP19 or any other genetic disorder should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing should be carefully considered in the context of an individual’s clinical symptoms, family history, and other relevant factors. |